Barely Significant

Excerpts

514,629 sentences

modestly significantP = 0.020.4× alphaqualifiedgold
Previously, the UGT1A7*3 allele exhibited modestly significant association with colorectal cancer (OR = 2.39; P = 0.02) [ 57 ], lung cancer [ 62 ], endometrial cancer [ 63 ] and pancreatic cancer (OR = 1.98; P = 0.003) [ 64 ] with a particularly strong association in smokers with pancreatic carcinoma who were younger than 55 years (OR = 4.7; P = 0.0009), suggesting the magnitude of the observed associations may be modified by environmental interactions.
a significant trendp = 0.020.4× alphagold
A similar relationship was observed when comparing females in the highest (≥ 5.62 ng/mL) versus lowest quartile (< 0.27 ng/mL) of EP in both unadjusted and adjusted models (FOR = 0.66; 95% CI: 0.47, 0.93, and aFOR = 0.66; 95% CI: 0.46, 0.95, respectively), reflecting in a significant trend ( p = 0.02).
marginally significantp = 0.020.4× alphagold
Tissue biomarker changes Although the median decrease in Ki-67 change in non-obese participants was similar among the three dosing regimens, the median reduction of 4% in Ki67 in the TIW dose schedule in obese women was less than the 8% median reduction in the QD arm which was marginally significant ( p = 0.02).
showed a trendp = 0.020.4× alpha
Similar results were obtained when analyzing the NTs in the EC of Cohort II; the co-localization between p-tau217/p-tau231 and p-tau231/p-tau205 was significantly lower, and p-tau217/p-tau205 showed a trend to lower co-localization in AD high compared to PART ( p = 0.02, p = 0.04, and p = 0.06, respectively).
The difference between IOP of injected eyes and their contralateral controls averaged over the course of the experiment was an increase of 3.8 +/− 2.81 mm Hg for vehicle-treated and 5.5 +/− 4.21 mm Hg for telmisartan-treated mice (mean +/− SD), but this difference did not reach statistical significance (except at day 14, P = 0.02, Student's t -test).
highly significantp<0.020.4× alphaqualifiedgold
However, consistent with the changes observed by phase contrast microscopy (Fig 1C ), we found a highly significant reduction in cell diameter of cells at CPD 73 from a mean of 27.7 μm (DMSO control) to 24.7 μm on AZD8055 treatment (unpaired t-test, p<0.02, Table 1 ), a cell diameter highly similar to that of low CPD untreated cells.
a nonsignificant trendp = 0.020.4× alphagold
Group differences in regional volumes Group comparisons ( t -tests) showed right putamen volume loss (HC: M = 0.35, SD = 0.05; PD-woMCI: M = 0.33, SD = 0.04; p = 0.005) and a nonsignificant trend for left putamen volume loss (HC: M = 0.36, SD = 0.06; PD-woMCI: M = 0.34, SD = 0.04; p = 0.02) in the PD-woMCI group.